The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis

BACKGROUND: The timely and effective treatments are vital to the prognosis of patients with hepatocellular carcinoma, and the role of Apatinib combined with TACE in the treatment of hepatocellular carcinoma remains unclear. Therefore, we aimed to conduct a systematic review and meta-analysis to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Anan, Li, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897864/
https://www.ncbi.nlm.nih.gov/pubmed/35246145
http://dx.doi.org/10.1186/s12957-021-02451-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897864/
https://www.ncbi.nlm.nih.gov/pubmed/35246145
http://dx.doi.org/10.1186/s12957-021-02451-8

Ejemplares similares